NCT01716533View on ClinicalTrials.gov

Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI)

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

February 2, 2013

Primary Completion Date

June 1, 2015

Study Completion Date

June 1, 2015

Conditions
Infections, Clostridium Difficile
Interventions
PROCEDURE

Blood sampling

Blood sampling will be done at Day 0, at Day 14, at recurrence (if applicable) and at end of follow-up.

OTHER

Stool sample collection

Stool samples will be collected around Day 0, around Day 14 and at recurrence (if applicable).

Trial Locations (5)

72205

GSK Investigational Site, Little Rock

77030

GSK Investigational Site, Houston

02215

GSK Investigational Site, Boston

L8N 4A6

GSK Investigational Site, Hamilton

M5G 1X5

GSK Investigational Site, Toronto

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01716533 - Evaluation of the Immune Response to Clostridium Difficile in Adults With Clostridium Difficile Infection (CDI) | Biotech Hunter | Biotech Hunter